Skip to content

SUPERNUS PHARMACEUTICALS INC

SUPN

Latest QuantConomy context for SUPN: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
20
Asset profile

SUPERNUS PHARMACEUTICALS INC

QuantConomy has a structured record for SUPN. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
SUPN
Name
SUPERNUS PHARMACEUTICALS INC
Coverage
3 market/data records
Sources
alphavantage alpaca fmp sec nasdaq openfigi
Latest signal rows

Recent signals for SUPN

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
earnings release
neutral
40
Feb 12, 12:00 AM SUPN filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).
earnings release
neutral
40
Feb 24, 12:00 AM SUPN filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-24. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).
other event
neutral
40
Jun 18, 09:00 PM SUPN filed 8-K: Shareholder Vote Results - [weak neutral signal]

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

Market coverage

Market Exchange Source Asset record
SUPN NASDAQ alphavantage Supernus Pharmaceuticals Inc
SUPN NASDAQ alpaca Supernus Pharmaceuticals, Inc. Common Stock
SUPN NASDAQ fmp Supernus Pharmaceuticals, Inc.

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
0
Rows
20
Date Insider Role Type Shares Price Value Filing
Mar 16, 2026 Bhatt Padmanabh P. Sr. VP of IP, CSO exercise 22,750 $36.75 $836,063 4 on EDGAR
Mar 13, 2026 Khattar Jack A. President, CEO other 12,500 4 on EDGAR
Mar 12, 2026 Hudson Frederick M. Insider sale 5,369 $50.61 $271,725 4 on EDGAR
Mar 6, 2026 Khattar Jack A. President, CEO exercise 38,640 $0.00 $0 4 on EDGAR
Mar 6, 2026 Horich William Todd SVP, Commercial Operations exercise 2,625 $0.00 $0 4 on EDGAR
Mar 6, 2026 DEC TIMOTHY C Senior Vice-President & CFO exercise 3,000 $0.00 $0 4 on EDGAR
Mar 6, 2026 Mottola Frank SVP, Chief Tech. Ops. Officer exercise 3,750 $0.00 $0 4 on EDGAR
Mar 5, 2026 GEMAYEL GEORGES Insider sale 10,000 $53.71 $537,100 4 on EDGAR
Horich William Todd SVP, Commercial Operations 3 on EDGAR
Feb 28, 2026 DEC TIMOTHY C Senior Vice-President & CFO grant 3,000 4 on EDGAR
Feb 28, 2026 Mottola Frank SVP, Chief Tech. Ops. Officer grant 3,750 4 on EDGAR
Feb 25, 2026 DEC TIMOTHY C Senior Vice-President & CFO grant 2,500 $0.00 $0 4 on EDGAR
Feb 24, 2026 Bhatt Padmanabh P. Sr. VP of IP, CSO grant 1,125 $0.00 $0 4 on EDGAR
Feb 24, 2026 Mottola Frank SVP, Chief Tech. Ops. Officer grant 1,125 $0.00 $0 4 on EDGAR
Feb 24, 2026 Hudson Frederick M. Insider grant 4,475 $0.00 $0 4 on EDGAR
Feb 24, 2026 Barlow Carrolee Insider grant 4,475 $0.00 $0 4 on EDGAR
Feb 24, 2026 NEWHALL CHARLES W III Insider grant 4,475 $0.00 $0 4 on EDGAR
Feb 24, 2026 Rubin Jonathan SVP, Chief Medical Officer grant 1,125 $0.00 $0 4 on EDGAR
Feb 24, 2026 DEC TIMOTHY C Senior Vice-President & CFO grant 1,125 $0.00 $0 4 on EDGAR
Feb 23, 2026 GEMAYEL GEORGES Insider exercise 15,000 $12.98 $194,700 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query SUPN context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access